Prognostic analysis of CD5 expression in double-hit diffuse large B-cell lymphoma and effectiveness comparison in patients treated with dose-adjusted EPOCH plus rituximab/R-CHOP regimens

OBJECTIVES: To compare the efficacy of rituximab, dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide and doxorubicin (DA-EPOCH-R) with traditional rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) regimens in CD5+ double-hit lymphoma (DHL) and to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fangwen, Li, Ling, Zhang, Lei, Li, Xin, Fu, Xiaorui, Wang, Xinhua, Wu, Jingjing, Sun, Zhenchang, Kong, Fei, Ren, Liangliang, Zhang, Mingzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707937/
https://www.ncbi.nlm.nih.gov/pubmed/31692510
http://dx.doi.org/10.2147/BLCTT.S216292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707937/
https://www.ncbi.nlm.nih.gov/pubmed/31692510
http://dx.doi.org/10.2147/BLCTT.S216292

Ejemplares similares